fluorouracil and ski 2053r

fluorouracil has been researched along with ski 2053r in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS	1
Bang, SJ; Cho, HR; Choi, DH; Kim, DH; Kim, GY; Ko, BK; Min, YJ; Park, JH; Shin, JW	1
Cho, YB; Kim, SY; Kuh, HJ; Lee, JW; Lee, SH; Park, JK	1

Trials

1 trial(s) available for fluorouracil and ski 2053r

Article	Year
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2 Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Creatinine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Leukopenia; Male; Malonates; Metabolic Clearance Rate; Metoclopramide; Middle Aged; Ondansetron; Organoplatinum Compounds; Proteinuria; Stomach Neoplasms; Survival Analysis; Vomiting	2002

Article

Year

Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.

Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Creatinine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Leukopenia; Male; Malonates; Metabolic Clearance Rate; Metoclopramide; Middle Aged; Ondansetron; Organoplatinum Compounds; Proteinuria; Stomach Neoplasms; Survival Analysis; Vomiting

2002

Other Studies

2 other study(ies) available for fluorouracil and ski 2053r

Article	Year
Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer. Journal of Korean medical science, 2004, Volume: 19, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Malonates; Middle Aged; Organoplatinum Compounds; Stomach Neoplasms; Time Factors; Treatment Outcome	2004
Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro. Anti-cancer drugs, 2006, Volume: 17, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Interactions; Fluorouracil; Head and Neck Neoplasms; Humans; Malonates; Organoplatinum Compounds; Paclitaxel	2006

Article

Year

Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer.

Journal of Korean medical science, 2004, Volume: 19, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Malonates; Middle Aged; Organoplatinum Compounds; Stomach Neoplasms; Time Factors; Treatment Outcome

2004

Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.

Anti-cancer drugs, 2006, Volume: 17, Issue:4

Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Interactions; Fluorouracil; Head and Neck Neoplasms; Humans; Malonates; Organoplatinum Compounds; Paclitaxel

2006